Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
HomeResearchPublished Research Articles
Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Author Information
Stabellini G, Balducci C, Lilli C, Marinucci L, Becchetti E, Carinci F, Calastrini C, Dolci C, Lumare E, Locci P.
Department of Human Morphology, State University of Milan, Via Mangiagalli 31, 20133 Milan, Italy.
Publication
Summary
Stay Up to Date as We Uncover More About Desmoid Tumors
